Centene Aktie News

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Centene To Contact Him Directly To Discuss Their Options

Centene's stock plunged after withdrawing 2025 guidance due to higher medical costs, but the selloff appears to be a capitulation event. The stock is deeply oversold, trading at just 10x reduced 2025 earnings, with a strong balance sheet and potential for a sharp rebound in 2026-2027. Challenges include Medicaid cuts and higher-risk policyholders, but corrective pricing actions and sector defen...

The Big Beautiful Bill Act cuts $1 trillion from Medicaid from which Centene gets 58% of its revenue. After plunging 40% will the stock drop more?

CNC has been deeply punished for the suspended FY2025 adj EPS guidance, after supposedly reiterating the prior numbers in the FQ1'25 earnings call. It is apparent that the higher medical care activities have impacted the healthcare providers'/ insurance's bottom-lines, worsened by the headwinds arising from One Big Beautiful Bill. Even so, the worst may already be baked into CNC's overly discou...

For healthcare stock Centene NYSE: CNC, July 2 was indisputably disastrous. Shares closed down by over 40% that day, resulting in the firm losing over $11 billion in market capitalization.

NEWTOWN, Pa., July 07, 2025 (GLOBE NEWSWIRE) -- Edelson Lechtzin LLP is investigating potential violations of the federal securities laws involving Centene Corporation (“Centene”) (NYSE: CNC), resulting from allegations of providing potentially misleading business information to the investing public.

NEW YORK, July 07, 2025 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, is investigating potential claims against Centene Corporation (“Centene” or the “Company”) (NYSE:CNC) on behalf of Centene stockholders. Our investigation concerns whether Centene has violated the federal securities laws and/or engaged in other unlawful business practices.

SAN FRANCISCO , July 7, 2025 /PRNewswire/ -- On July 2, 2025, investors in Centene Corp. (NYSE: CNC) saw the price of their shares of this normally low-volatility stock crash 40%, after the company withdrew its guidance, blaming preliminary discussions and data generated by an independent actuary, Wakely. The unusual circumstances and severe investor reaction has prompted national shareholders ...